Blunted P300 prospectively bridges cognitive reappraisal and depressive symptoms

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 558549

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2025
  • Known Financial Commitments (USD)

    $1,316.26
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Kehan Li
  • Research Location

    Canada
  • Lead Research Institution

    University of Alberta
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures
  • Research Subcategory

    Indirect health impacts
  • Special Interest Tags

    N/A
  • Study Type

    Clinical
  • Clinical Trial Details

    Not applicable
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract

Cognitive reappraisal is a crucial modulator of depression. Scant research has examined how usage of cognitive reappraisal could prospectively influence depressive symptoms through its modulation effect on P300. Moreover, there is limited knowledge about how the social-environmental context, such as stressful societal disruption, could moderate this prospective process. Adopting a 6-month longitudinal design that recorded both behavioral and electroencephalogram data among 55 young adults (61.8% female) during the COVID-19 pandemic, this study examined the prospective associations from participants' Wave 1 [W1] usage of cognitive reappraisal strategy to W3 depressive symptoms through W2 P300 amplitude during an oddball task, and investigated the potential moderation effect of COVID-19 stress on this mediation path. Cognitive reappraisal was prospectively and indirectly linked to depressive symptoms through reduced P300 amplitude, which was suppressed by COVID-19 stress. Participants with more frequent use of cognitive reappraisal showed blunted P300 amplitude only when COVID-19 stress was low, which was subsequently linked to elevated depressive symptoms. Current findings highlight the central role of reduced P300 as a mediator between cognitive reappraisal and exacerbation of vulnerability for depressive symptoms. Moreover, current findings emphasize the interactive influence between the social-environmental context and cognitive strategy on psychiatric symptoms on a long-term timescale.